Australia markets close in 37 minutes

TFF Pharmaceuticals, Inc. (TFFP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.760.00 (0.00%)
At close: 04:00PM EDT
5.76 0.00 (0.00%)
After hours: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close5.76
Open5.72
Bid0.00 x 2200
Ask0.00 x 1000
Day's range5.54 - 5.76
52-week range3.60 - 10.70
Volume34,913
Avg. volume107,864
Market cap146.153M
Beta (5Y monthly)2.12
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    TFF Pharmaceuticals to Participate at The JMP Securities Life Sciences Conference

    FORT WORTH, Texas, June 09, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that President and CEO Glenn Mattes will be participating in the JMP Securities Life Sciences Conference being held June 15 – 16, 2022 at the Lotte New York Palace in New York City. Company management will also

  • GlobeNewswire

    TFF Pharmaceuticals to Participate at the Jefferies Healthcare Conference

    FORT WORTH, Texas, June 01, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that President and CEO Glenn Mattes will be participating in the Jefferies Healthcare Conference being held June 8 – 10, 2022 in New York City. Company management will also be participating in one-on-one meeting

  • GlobeNewswire

    TFF Pharmaceuticals to Participate at the H.C. Wainwright Global Investment Conference

    FORT WORTH, Texas, May 20, 2022 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced that President and CEO Glenn Mattes will be virtually participating in the H.C. Wainwright Global Investment Conference being held May 23 - 26, 2022. Company management will also be participating in virtual one-o